

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.31676951 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 5.31676951 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.30909567 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 5.30909567 |
| 5 | glyoxylate metabolic process (GO:0046487) | 5.17600840 |
| 6 | aromatic amino acid family catabolic process (GO:0009074) | 5.08203947 |
| 7 | * sulfur amino acid catabolic process (GO:0000098) | 5.02173642 |
| 8 | indole-containing compound catabolic process (GO:0042436) | 4.89799248 |
| 9 | indolalkylamine catabolic process (GO:0046218) | 4.89799248 |
| 10 | tryptophan catabolic process (GO:0006569) | 4.89799248 |
| 11 | cysteine metabolic process (GO:0006534) | 4.78079501 |
| 12 | cellular ketone body metabolic process (GO:0046950) | 4.65585575 |
| 13 | regulation of vitamin metabolic process (GO:0030656) | 4.59791699 |
| 14 | tryptophan metabolic process (GO:0006568) | 4.54331229 |
| 15 | kynurenine metabolic process (GO:0070189) | 4.52900919 |
| 16 | bile acid and bile salt transport (GO:0015721) | 4.38821772 |
| 17 | flavonoid metabolic process (GO:0009812) | 4.38661006 |
| 18 | bile acid biosynthetic process (GO:0006699) | 4.22050013 |
| 19 | serine family amino acid catabolic process (GO:0009071) | 4.20754814 |
| 20 | lysine catabolic process (GO:0006554) | 4.19708101 |
| 21 | lysine metabolic process (GO:0006553) | 4.19708101 |
| 22 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.15455073 |
| 23 | homocysteine metabolic process (GO:0050667) | 4.15395202 |
| 24 | cellular glucuronidation (GO:0052695) | 4.14701291 |
| 25 | drug transmembrane transport (GO:0006855) | 4.09225524 |
| 26 | amino-acid betaine metabolic process (GO:0006577) | 4.09066300 |
| 27 | ketone body metabolic process (GO:1902224) | 4.00486937 |
| 28 | serine family amino acid biosynthetic process (GO:0009070) | 3.96119627 |
| 29 | urate metabolic process (GO:0046415) | 3.87409090 |
| 30 | serine family amino acid metabolic process (GO:0009069) | 3.84741560 |
| 31 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.83126372 |
| 32 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.81484426 |
| 33 | glycine metabolic process (GO:0006544) | 3.80053959 |
| 34 | bile acid metabolic process (GO:0008206) | 3.77342306 |
| 35 | aromatic amino acid family metabolic process (GO:0009072) | 3.75838541 |
| 36 | urea metabolic process (GO:0019627) | 3.75768628 |
| 37 | urea cycle (GO:0000050) | 3.75768628 |
| 38 | glucuronate metabolic process (GO:0019585) | 3.74719863 |
| 39 | uronic acid metabolic process (GO:0006063) | 3.74719863 |
| 40 | drug transport (GO:0015893) | 3.73749162 |
| 41 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.67784681 |
| 42 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.67784681 |
| 43 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.61937694 |
| 44 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.61937694 |
| 45 | GDP-mannose metabolic process (GO:0019673) | 3.60355708 |
| 46 | alpha-amino acid catabolic process (GO:1901606) | 3.55337096 |
| 47 | negative regulation of cholesterol transport (GO:0032375) | 3.54473506 |
| 48 | negative regulation of sterol transport (GO:0032372) | 3.54473506 |
| 49 | drug catabolic process (GO:0042737) | 3.54155321 |
| 50 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 3.52003904 |
| 51 | nitrogen cycle metabolic process (GO:0071941) | 3.52002784 |
| 52 | short-chain fatty acid metabolic process (GO:0046459) | 3.51797288 |
| 53 | valine metabolic process (GO:0006573) | 3.49339007 |
| 54 | ethanol oxidation (GO:0006069) | 3.45994943 |
| 55 | alpha-linolenic acid metabolic process (GO:0036109) | 3.45830692 |
| 56 | aldehyde catabolic process (GO:0046185) | 3.44396720 |
| 57 | * cellular amino acid catabolic process (GO:0009063) | 3.40917921 |
| 58 | glycosphingolipid catabolic process (GO:0046479) | 3.40179948 |
| 59 | benzene-containing compound metabolic process (GO:0042537) | 3.38736215 |
| 60 | adhesion of symbiont to host cell (GO:0044650) | 3.38079808 |
| 61 | virion attachment to host cell (GO:0019062) | 3.38079808 |
| 62 | complement activation, alternative pathway (GO:0006957) | 3.37510218 |
| 63 | negative regulation of fibrinolysis (GO:0051918) | 3.37204516 |
| 64 | fatty acid beta-oxidation (GO:0006635) | 3.36238642 |
| 65 | exogenous drug catabolic process (GO:0042738) | 3.34864097 |
| 66 | fatty acid oxidation (GO:0019395) | 3.34845735 |
| 67 | cellular biogenic amine catabolic process (GO:0042402) | 3.34152443 |
| 68 | amine catabolic process (GO:0009310) | 3.34152443 |
| 69 | indolalkylamine metabolic process (GO:0006586) | 3.32606956 |
| 70 | protein carboxylation (GO:0018214) | 3.32172444 |
| 71 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.32172444 |
| 72 | regulation of triglyceride catabolic process (GO:0010896) | 3.31939674 |
| 73 | NAD biosynthetic process (GO:0009435) | 3.30851489 |
| 74 | regulation of protein activation cascade (GO:2000257) | 3.30781670 |
| 75 | carnitine metabolic process (GO:0009437) | 3.30231703 |
| 76 | lipid oxidation (GO:0034440) | 3.28494876 |
| 77 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.27203870 |
| 78 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.27203870 |
| 79 | high-density lipoprotein particle remodeling (GO:0034375) | 3.25086157 |
| 80 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.23132861 |
| 81 | angiotensin maturation (GO:0002003) | 3.21086680 |
| 82 | * carboxylic acid catabolic process (GO:0046395) | 3.17181122 |
| 83 | * organic acid catabolic process (GO:0016054) | 3.17181122 |
| 84 | cellular modified amino acid catabolic process (GO:0042219) | 3.16606709 |
| 85 | 2-oxoglutarate metabolic process (GO:0006103) | 3.16580427 |
| 86 | glycolipid catabolic process (GO:0019377) | 3.13844811 |
| 87 | regulation of fibrinolysis (GO:0051917) | 3.12749914 |
| 88 | imidazole-containing compound metabolic process (GO:0052803) | 3.11547113 |
| 89 | regulation of complement activation (GO:0030449) | 3.10994708 |
| 90 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 3.10380267 |
| 91 | low-density lipoprotein particle remodeling (GO:0034374) | 3.08606041 |
| 92 | fatty acid catabolic process (GO:0009062) | 3.08516644 |
| 93 | protein-lipid complex remodeling (GO:0034368) | 3.08062803 |
| 94 | macromolecular complex remodeling (GO:0034367) | 3.08062803 |
| 95 | plasma lipoprotein particle remodeling (GO:0034369) | 3.08062803 |
| 96 | branched-chain amino acid metabolic process (GO:0009081) | 3.05251059 |
| 97 | monocarboxylic acid catabolic process (GO:0072329) | 3.04351890 |
| 98 | killing of cells of other organism (GO:0031640) | 3.04054990 |
| 99 | disruption of cells of other organism (GO:0044364) | 3.04054990 |
| 100 | branched-chain amino acid catabolic process (GO:0009083) | 3.03799108 |
| 101 | NIK/NF-kappaB signaling (GO:0038061) | 3.02916630 |
| 102 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.02590234 |
| 103 | tyrosine metabolic process (GO:0006570) | 3.01917866 |
| 104 | heme transport (GO:0015886) | 3.01202844 |
| 105 | drug metabolic process (GO:0017144) | 3.00968440 |
| 106 | intestinal absorption (GO:0050892) | 2.99640461 |
| 107 | regulation of cholesterol esterification (GO:0010872) | 2.98006302 |
| 108 | fructose metabolic process (GO:0006000) | 2.97998236 |
| 109 | immunoglobulin mediated immune response (GO:0016064) | 2.97232577 |
| 110 | * sulfur amino acid metabolic process (GO:0000096) | 2.95941954 |
| 111 | regulation of cholesterol metabolic process (GO:0090181) | 2.95780654 |
| 112 | phospholipid efflux (GO:0033700) | 2.95308833 |
| 113 | pinocytosis (GO:0006907) | 2.94953296 |
| 114 | eosinophil chemotaxis (GO:0048245) | 2.94762609 |
| 115 | adhesion of symbiont to host (GO:0044406) | 2.94092812 |
| 116 | coenzyme catabolic process (GO:0009109) | 2.93212557 |
| 117 | pyrimidine nucleoside catabolic process (GO:0046135) | 2.92755387 |
| 118 | NAD metabolic process (GO:0019674) | 2.91869779 |
| 119 | positive regulation of pseudopodium assembly (GO:0031274) | 2.90915974 |
| 120 | response to nitrosative stress (GO:0051409) | 2.89772190 |
| 121 | L-serine metabolic process (GO:0006563) | 2.89724457 |
| 122 | barbed-end actin filament capping (GO:0051016) | 2.89466888 |
| 123 | regulation of respiratory burst (GO:0060263) | 2.86933524 |
| 124 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.86249441 |
| 125 | cellular response to zinc ion (GO:0071294) | 2.77239030 |
| 126 | regulation of metalloenzyme activity (GO:0048552) | 2.77065097 |
| 127 | neutrophil activation involved in immune response (GO:0002283) | 2.76658577 |
| 128 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.73821599 |
| 129 | mature B cell differentiation involved in immune response (GO:0002313) | 2.73104368 |
| 130 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.71543152 |
| 131 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.71463345 |
| 132 | ceramide catabolic process (GO:0046514) | 2.68502877 |
| 133 | desmosome organization (GO:0002934) | 2.68036438 |
| 134 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.67617970 |
| 135 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.65569503 |
| 136 | sphingolipid catabolic process (GO:0030149) | 2.64108365 |
| 137 | regulation of mononuclear cell migration (GO:0071675) | 2.63395130 |
| 138 | eosinophil migration (GO:0072677) | 2.62620072 |
| 139 | response to peptidoglycan (GO:0032494) | 2.60830074 |
| 140 | positive regulation of respiratory burst (GO:0060267) | 2.59366787 |
| 141 | oligosaccharide catabolic process (GO:0009313) | 2.59268951 |
| 142 | regulation of cellular extravasation (GO:0002691) | 2.57266646 |
| 143 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.56763406 |
| 144 | regulation of podosome assembly (GO:0071801) | 2.54778340 |
| 145 | NADH metabolic process (GO:0006734) | 2.54357575 |
| 146 | membrane lipid catabolic process (GO:0046466) | 2.53156101 |
| 147 | cyclooxygenase pathway (GO:0019371) | 2.51706750 |
| 148 | regulation of pseudopodium assembly (GO:0031272) | 2.51395478 |
| 149 | negative regulation of protein tyrosine kinase activity (GO:0061099) | 2.48793168 |
| 150 | oligosaccharide biosynthetic process (GO:0009312) | 2.44118716 |
| 151 | regulation of monocyte chemotaxis (GO:0090025) | 2.42077439 |
| 152 | renal system process involved in regulation of blood volume (GO:0001977) | 2.41621854 |
| 153 | regulation of chemokine biosynthetic process (GO:0045073) | 2.40943877 |
| 154 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.38165320 |
| 155 | transcytosis (GO:0045056) | 2.35752722 |
| 156 | antimicrobial humoral response (GO:0019730) | 2.34877685 |
| 157 | purine nucleotide salvage (GO:0032261) | 2.34791809 |
| 158 | regulation of antigen processing and presentation (GO:0002577) | 2.32839491 |
| 159 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.32442403 |
| 160 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.32325847 |
| 161 | regulation of superoxide anion generation (GO:0032928) | 2.31217405 |
| 162 | negative regulation of receptor activity (GO:2000272) | 2.29303894 |
| 163 | B cell mediated immunity (GO:0019724) | 2.26798306 |
| 164 | positive regulation of antigen processing and presentation (GO:0002579) | 2.23824533 |
| 165 | cellular response to pH (GO:0071467) | 2.23211365 |
| 166 | type I interferon signaling pathway (GO:0060337) | 2.22962715 |
| 167 | cellular response to type I interferon (GO:0071357) | 2.22962715 |
| 168 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.22878591 |
| 169 | antibacterial humoral response (GO:0019731) | 2.21979370 |
| 170 | hyaluronan catabolic process (GO:0030214) | 2.20438454 |
| 171 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.19681865 |
| 172 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.19584281 |
| 173 | response to type I interferon (GO:0034340) | 2.18292901 |
| 174 | regulation of intracellular pH (GO:0051453) | 2.18022178 |
| 175 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.18008440 |
| 176 | sulfate transmembrane transport (GO:1902358) | 2.17894303 |
| 177 | regulation of RIG-I signaling pathway (GO:0039535) | 2.16888174 |
| 178 | regulation of guanylate cyclase activity (GO:0031282) | 2.16066856 |
| 179 | glycoside metabolic process (GO:0016137) | 2.13912249 |
| 180 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 2.13503725 |
| 181 | nucleotide salvage (GO:0043173) | 2.13166932 |
| 182 | decidualization (GO:0046697) | 2.13098997 |
| 183 | epoxygenase P450 pathway (GO:0019373) | 2.11958040 |
| 184 | regulation of plasminogen activation (GO:0010755) | 2.11948556 |
| 185 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.11533871 |
| 186 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.11257769 |
| 187 | deoxyribonucleotide catabolic process (GO:0009264) | 2.09244886 |
| 188 | arginine catabolic process (GO:0006527) | 2.09229250 |
| 189 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.08779789 |
| 190 | response to interferon-beta (GO:0035456) | 2.07650378 |
| 191 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.07287481 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 7.42723328 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.08988897 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.75815285 |
| 4 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.48517742 |
| 5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.48487335 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.61490202 |
| 7 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.49219357 |
| 8 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.97241884 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.77075093 |
| 10 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.74803200 |
| 11 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.73673972 |
| 12 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.54310166 |
| 13 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.48862653 |
| 14 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.14926936 |
| 15 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.00057126 |
| 16 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.78318319 |
| 17 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.77384186 |
| 18 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.71705268 |
| 19 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.71560752 |
| 20 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.70400543 |
| 21 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.68832228 |
| 22 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.67274419 |
| 23 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.59891086 |
| 24 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.58611669 |
| 25 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.58121219 |
| 26 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.57911834 |
| 27 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.57643525 |
| 28 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.55981784 |
| 29 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.55912589 |
| 30 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.54036417 |
| 31 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.53849708 |
| 32 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.53450910 |
| 33 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.52826235 |
| 34 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.52512920 |
| 35 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.52357200 |
| 36 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.49151122 |
| 37 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.46624696 |
| 38 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.46408917 |
| 39 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.43382541 |
| 40 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.38339904 |
| 41 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.35074280 |
| 42 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.34563897 |
| 43 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.33792590 |
| 44 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.30531409 |
| 45 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.28678607 |
| 46 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.28261161 |
| 47 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.26232172 |
| 48 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.25316717 |
| 49 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.24822771 |
| 50 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24292460 |
| 51 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.23753137 |
| 52 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.23630383 |
| 53 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.23592905 |
| 54 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.23241145 |
| 55 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.22845020 |
| 56 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.22329770 |
| 57 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.21286009 |
| 58 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.21086140 |
| 59 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.20793897 |
| 60 | GATA1_22025678_ChIP-Seq_K562_Human | 1.19684120 |
| 61 | ATF3_27146783_Chip-Seq_COLON_Human | 1.17839512 |
| 62 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.17735500 |
| 63 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.16897047 |
| 64 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.16248664 |
| 65 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.15596828 |
| 66 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.13512338 |
| 67 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.12934209 |
| 68 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.12296068 |
| 69 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.12049122 |
| 70 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.11960973 |
| 71 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.11948490 |
| 72 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.11725249 |
| 73 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.11412978 |
| 74 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.11372977 |
| 75 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.10645474 |
| 76 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.10213470 |
| 77 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.10098824 |
| 78 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08855686 |
| 79 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.08324452 |
| 80 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.08323714 |
| 81 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.08164467 |
| 82 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.07374108 |
| 83 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.06899334 |
| 84 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.06853195 |
| 85 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.06609948 |
| 86 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.05862136 |
| 87 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.02954437 |
| 88 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.02772116 |
| 89 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.02449954 |
| 90 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.02134700 |
| 91 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.02122496 |
| 92 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.01607022 |
| 93 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.01352086 |
| 94 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.00765756 |
| 95 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99686966 |
| 96 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.99350561 |
| 97 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.99279468 |
| 98 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.98799705 |
| 99 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.98522489 |
| 100 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.98500212 |
| 101 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.98500212 |
| 102 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.98066362 |
| 103 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.97997580 |
| 104 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.97058252 |
| 105 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.96975916 |
| 106 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.96642235 |
| 107 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.96508032 |
| 108 | SA1_27219007_Chip-Seq_Bcells_Human | 0.96036025 |
| 109 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.95970459 |
| 110 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.94658547 |
| 111 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.94199241 |
| 112 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.93364122 |
| 113 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.93238964 |
| 114 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.92391811 |
| 115 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.89937833 |
| 116 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 0.89653701 |
| 117 | * BCL6_27268052_Chip-Seq_Bcells_Human | 0.89599586 |
| 118 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.89134430 |
| 119 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.89045114 |
| 120 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.88119576 |
| 121 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.86647221 |
| 122 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.85514308 |
| 123 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.85009749 |
| 124 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.84855793 |
| 125 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.84246242 |
| 126 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.84236592 |
| 127 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.84127412 |
| 128 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 0.83830249 |
| 129 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.83408000 |
| 130 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.83072220 |
| 131 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.82980429 |
| 132 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.82588628 |
| 133 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.82485068 |
| 134 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.82041520 |
| 135 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.81869447 |
| 136 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.81850694 |
| 137 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.81619407 |
| 138 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.81276664 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.00761806 |
| 2 | MP0005360_urolithiasis | 5.96023550 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 4.87475392 |
| 4 | MP0005365_abnormal_bile_salt | 4.86841768 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.16469586 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.04003131 |
| 7 | MP0003252_abnormal_bile_duct | 2.66973381 |
| 8 | MP0001666_abnormal_nutrient_absorption | 2.62993328 |
| 9 | MP0005332_abnormal_amino_acid | 2.59985679 |
| 10 | MP0009840_abnormal_foam_cell | 2.49677069 |
| 11 | MP0010329_abnormal_lipoprotein_level | 2.35042755 |
| 12 | MP0006082_CNS_inflammation | 2.31385536 |
| 13 | MP0004019_abnormal_vitamin_homeostasis | 2.21710030 |
| 14 | MP0003303_peritoneal_inflammation | 2.16695211 |
| 15 | MP0003186_abnormal_redox_activity | 2.13463769 |
| 16 | MP0003191_abnormal_cellular_cholesterol | 2.13387223 |
| 17 | MP0005083_abnormal_biliary_tract | 2.03033826 |
| 18 | MP0002138_abnormal_hepatobiliary_system | 1.98085253 |
| 19 | * MP0009643_abnormal_urine_homeostasis | 1.86171954 |
| 20 | MP0005319_abnormal_enzyme/_coenzyme | 1.80156918 |
| 21 | MP0003195_calcinosis | 1.77044558 |
| 22 | MP0000609_abnormal_liver_physiology | 1.71036822 |
| 23 | MP0001764_abnormal_homeostasis | 1.70911875 |
| 24 | MP0003183_abnormal_peptide_metabolism | 1.68759209 |
| 25 | MP0006054_spinal_hemorrhage | 1.67708517 |
| 26 | MP0005451_abnormal_body_composition | 1.65002555 |
| 27 | MP0001790_abnormal_immune_system | 1.61790778 |
| 28 | MP0005387_immune_system_phenotype | 1.61790778 |
| 29 | MP0010155_abnormal_intestine_physiology | 1.59993050 |
| 30 | MP0009785_altered_susceptibility_to | 1.59192976 |
| 31 | * MP0005636_abnormal_mineral_homeostasis | 1.57269480 |
| 32 | MP0001533_abnormal_skeleton_physiology | 1.56911786 |
| 33 | MP0003868_abnormal_feces_composition | 1.52065664 |
| 34 | MP0002118_abnormal_lipid_homeostasis | 1.49966975 |
| 35 | * MP0005584_abnormal_enzyme/coenzyme_acti | 1.47440217 |
| 36 | MP0006036_abnormal_mitochondrial_physio | 1.44915851 |
| 37 | MP0008438_abnormal_cutaneous_collagen | 1.44443193 |
| 38 | MP0003866_abnormal_defecation | 1.38399518 |
| 39 | MP0003172_abnormal_lysosome_physiology | 1.37849640 |
| 40 | MP0005058_abnormal_lysosome_morphology | 1.37105289 |
| 41 | MP0003300_gastrointestinal_ulcer | 1.36568675 |
| 42 | MP0001873_stomach_inflammation | 1.32721592 |
| 43 | MP0009764_decreased_sensitivity_to | 1.32485966 |
| 44 | MP0003436_decreased_susceptibility_to | 1.32219660 |
| 45 | MP0005023_abnormal_wound_healing | 1.31771653 |
| 46 | MP0000858_altered_metastatic_potential | 1.31301142 |
| 47 | MP0008469_abnormal_protein_level | 1.30580179 |
| 48 | MP0003724_increased_susceptibility_to | 1.30346491 |
| 49 | MP0001663_abnormal_digestive_system | 1.28822799 |
| 50 | MP0005084_abnormal_gallbladder_morpholo | 1.28441584 |
| 51 | MP0004264_abnormal_extraembryonic_tissu | 1.27311484 |
| 52 | MP0003656_abnormal_erythrocyte_physiolo | 1.27298762 |
| 53 | MP0001853_heart_inflammation | 1.26036119 |
| 54 | MP0010352_gastrointestinal_tract_polyps | 1.24585623 |
| 55 | MP0001542_abnormal_bone_strength | 1.23517429 |
| 56 | MP0000343_altered_response_to | 1.23208927 |
| 57 | MP0005165_increased_susceptibility_to | 1.20406788 |
| 58 | MP0001756_abnormal_urination | 1.16469380 |
| 59 | MP0005025_abnormal_response_to | 1.16426655 |
| 60 | MP0004510_myositis | 1.14801671 |
| 61 | MP0000490_abnormal_crypts_of | 1.14473243 |
| 62 | MP0001835_abnormal_antigen_presentation | 1.12940286 |
| 63 | MP0000598_abnormal_liver_morphology | 1.12613650 |
| 64 | MP0002796_impaired_skin_barrier | 1.11161965 |
| 65 | MP0005670_abnormal_white_adipose | 1.09075641 |
| 66 | MP0001845_abnormal_inflammatory_respons | 1.08503125 |
| 67 | MP0001765_abnormal_ion_homeostasis | 1.06760820 |
| 68 | MP0003448_altered_tumor_morphology | 1.06646009 |
| 69 | MP0005257_abnormal_intraocular_pressure | 1.06594117 |
| 70 | MP0002136_abnormal_kidney_physiology | 1.03590321 |
| 71 | MP0005464_abnormal_platelet_physiology | 1.02956083 |
| 72 | MP0000604_amyloidosis | 1.02317462 |
| 73 | MP0005381_digestive/alimentary_phenotyp | 1.01922636 |
| 74 | MP0010234_abnormal_vibrissa_follicle | 1.00133449 |
| 75 | MP0008004_abnormal_stomach_pH | 0.99163061 |
| 76 | MP0004147_increased_porphyrin_level | 0.98081000 |
| 77 | MP0005377_hearing/vestibular/ear_phenot | 0.97108807 |
| 78 | MP0003878_abnormal_ear_physiology | 0.97108807 |
| 79 | MP0008260_abnormal_autophagy | 0.96902455 |
| 80 | MP0002060_abnormal_skin_morphology | 0.96292277 |
| 81 | MP0002419_abnormal_innate_immunity | 0.95391091 |
| 82 | MP0003453_abnormal_keratinocyte_physiol | 0.94231736 |
| 83 | MP0003693_abnormal_embryo_hatching | 0.92755527 |
| 84 | MP0001849_ear_inflammation | 0.92556083 |
| 85 | MP0000477_abnormal_intestine_morphology | 0.92289385 |
| 86 | MP0001216_abnormal_epidermal_layer | 0.91141166 |
| 87 | MP0006035_abnormal_mitochondrial_morpho | 0.90356763 |
| 88 | MP0003950_abnormal_plasma_membrane | 0.90019362 |
| 89 | MP0009379_abnormal_foot_pigmentation | 0.89402691 |
| 90 | MP0004043_abnormal_pH_regulation | 0.89145747 |
| 91 | MP0003279_aneurysm | 0.88861859 |
| 92 | MP0002822_catalepsy | 0.88211355 |
| 93 | MP0002998_abnormal_bone_remodeling | 0.88025976 |
| 94 | * MP0009642_abnormal_blood_homeostasis | 0.88012847 |
| 95 | MP0009763_increased_sensitivity_to | 0.87764011 |
| 96 | MP0000678_abnormal_parathyroid_gland | 0.87157974 |
| 97 | MP0002148_abnormal_hypersensitivity_rea | 0.86592352 |
| 98 | MP0002396_abnormal_hematopoietic_system | 0.86522233 |
| 99 | MP0001664_abnormal_digestion | 0.85658532 |
| 100 | MP0005390_skeleton_phenotype | 0.84275984 |
| 101 | MP0000685_abnormal_immune_system | 0.83126052 |
| 102 | MP0005164_abnormal_response_to | 0.82816889 |
| 103 | MP0005310_abnormal_salivary_gland | 0.82437313 |
| 104 | MP0005167_abnormal_blood-brain_barrier | 0.81899485 |
| 105 | MP0002876_abnormal_thyroid_physiology | 0.79730375 |
| 106 | MP0005501_abnormal_skin_physiology | 0.79631921 |
| 107 | MP0005166_decreased_susceptibility_to | 0.79470522 |
| 108 | MP0008873_increased_physiological_sensi | 0.78639029 |
| 109 | MP0002254_reproductive_system_inflammat | 0.78365375 |
| 110 | MP0001800_abnormal_humoral_immune | 0.76155613 |
| 111 | * MP0005376_homeostasis/metabolism_phenot | 0.75038374 |
| 112 | MP0003705_abnormal_hypodermis_morpholog | 0.73702792 |
| 113 | MP0002132_abnormal_respiratory_system | 0.72935977 |
| 114 | MP0004947_skin_inflammation | 0.72886399 |
| 115 | MP0000465_gastrointestinal_hemorrhage | 0.72619079 |
| 116 | MP0002166_altered_tumor_susceptibility | 0.68530095 |
| 117 | MP0002452_abnormal_antigen_presenting | 0.67850247 |
| 118 | MP0009333_abnormal_splenocyte_physiolog | 0.67723235 |
| 119 | MP0001545_abnormal_hematopoietic_system | 0.67643409 |
| 120 | MP0005397_hematopoietic_system_phenotyp | 0.67643409 |
| 121 | MP0002723_abnormal_immune_serum | 0.67562725 |
| 122 | MP0003646_muscle_fatigue | 0.65920273 |
| 123 | MP0005408_hypopigmentation | 0.65326251 |
| 124 | MP0009765_abnormal_xenobiotic_induced | 0.64395669 |
| 125 | MP0005671_abnormal_response_to | 0.64307669 |
| 126 | MP0003638_abnormal_response/metabolism_ | 0.62541692 |
| 127 | * MP0005266_abnormal_metabolism | 0.62332610 |
| 128 | MP0009697_abnormal_copulation | 0.62235268 |
| 129 | MP0003718_maternal_effect | 0.62015086 |
| 130 | MP0001819_abnormal_immune_cell | 0.61379822 |
| 131 | MP0005000_abnormal_immune_tolerance | 0.61051950 |
| 132 | MP0000689_abnormal_spleen_morphology | 0.60873303 |
| 133 | MP0002420_abnormal_adaptive_immunity | 0.60129952 |
| 134 | MP0004782_abnormal_surfactant_physiolog | 0.58524829 |
| 135 | MP0003075_altered_response_to | 0.58483320 |
| 136 | MP0003011_delayed_dark_adaptation | 0.58195893 |
| 137 | MP0005647_abnormal_sex_gland | 0.57004063 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.05443658 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 4.85741152 |
| 3 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.74591427 |
| 4 | Xanthomatosis (HP:0000991) | 4.06669744 |
| 5 | Hyperammonemia (HP:0001987) | 3.92561685 |
| 6 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.88395102 |
| 7 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.88395102 |
| 8 | Abnormality of glycolipid metabolism (HP:0010969) | 3.88395102 |
| 9 | Deep venous thrombosis (HP:0002625) | 3.84782462 |
| 10 | Prolonged partial thromboplastin time (HP:0003645) | 3.83734850 |
| 11 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.77952748 |
| 12 | Hypobetalipoproteinemia (HP:0003563) | 3.77325819 |
| 13 | Hyperglycinuria (HP:0003108) | 3.77233338 |
| 14 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.56346543 |
| 15 | Hyperglycinemia (HP:0002154) | 3.54928112 |
| 16 | Hypoglycemic coma (HP:0001325) | 3.51843380 |
| 17 | Generalized aminoaciduria (HP:0002909) | 3.49959115 |
| 18 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.41312838 |
| 19 | Abnormality of glycine metabolism (HP:0010895) | 3.41312838 |
| 20 | * Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.34761485 |
| 21 | * Dicarboxylic aciduria (HP:0003215) | 3.34761485 |
| 22 | Hyperlipoproteinemia (HP:0010980) | 3.33383943 |
| 23 | Dysostosis multiplex (HP:0000943) | 3.23458295 |
| 24 | Ketosis (HP:0001946) | 3.22902685 |
| 25 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.15630673 |
| 26 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.12860783 |
| 27 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.07253935 |
| 28 | Fat malabsorption (HP:0002630) | 3.05289902 |
| 29 | Proximal tubulopathy (HP:0000114) | 3.04882612 |
| 30 | Gout (HP:0001997) | 3.02872028 |
| 31 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.02867776 |
| 32 | Joint hemorrhage (HP:0005261) | 3.02737522 |
| 33 | Hepatic necrosis (HP:0002605) | 3.00558656 |
| 34 | Lethargy (HP:0001254) | 2.89487708 |
| 35 | Complement deficiency (HP:0004431) | 2.86825042 |
| 36 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.84319540 |
| 37 | Abnormality of nucleobase metabolism (HP:0010932) | 2.83036146 |
| 38 | Hyperbilirubinemia (HP:0002904) | 2.80524318 |
| 39 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.77974501 |
| 40 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.77974501 |
| 41 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.77974501 |
| 42 | Abnormality of methionine metabolism (HP:0010901) | 2.77791599 |
| 43 | Hypolipoproteinemia (HP:0010981) | 2.77407469 |
| 44 | Abnormality of macrophages (HP:0004311) | 2.73471463 |
| 45 | Mucopolysacchariduria (HP:0008155) | 2.72057460 |
| 46 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.72057460 |
| 47 | Abnormality of urine glucose concentration (HP:0011016) | 2.72042341 |
| 48 | Glycosuria (HP:0003076) | 2.72042341 |
| 49 | Alkalosis (HP:0001948) | 2.70991863 |
| 50 | Cerebral edema (HP:0002181) | 2.68680027 |
| 51 | Abnormality of purine metabolism (HP:0004352) | 2.68123828 |
| 52 | Delayed CNS myelination (HP:0002188) | 2.63022975 |
| 53 | Metabolic acidosis (HP:0001942) | 2.60469188 |
| 54 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.60335751 |
| 55 | Abnormality of the common coagulation pathway (HP:0010990) | 2.59262796 |
| 56 | Increased muscle lipid content (HP:0009058) | 2.56623761 |
| 57 | Vertebral compression fractures (HP:0002953) | 2.56545745 |
| 58 | Malnutrition (HP:0004395) | 2.54518955 |
| 59 | Conjugated hyperbilirubinemia (HP:0002908) | 2.54254410 |
| 60 | Nausea (HP:0002018) | 2.51826056 |
| 61 | Ketoacidosis (HP:0001993) | 2.51562967 |
| 62 | Abnormality of serum amino acid levels (HP:0003112) | 2.50317020 |
| 63 | Abnormal tarsal ossification (HP:0008369) | 2.48060705 |
| 64 | Vacuolated lymphocytes (HP:0001922) | 2.47234282 |
| 65 | Hepatocellular necrosis (HP:0001404) | 2.41021137 |
| 66 | Steatorrhea (HP:0002570) | 2.40539814 |
| 67 | Abnormality of proline metabolism (HP:0010907) | 2.40079875 |
| 68 | Hydroxyprolinuria (HP:0003080) | 2.40079875 |
| 69 | Loss of speech (HP:0002371) | 2.38725257 |
| 70 | Abnormal cartilage morphology (HP:0002763) | 2.37036362 |
| 71 | Increased intramyocellular lipid droplets (HP:0012240) | 2.36369978 |
| 72 | Acute encephalopathy (HP:0006846) | 2.35240472 |
| 73 | Vomiting (HP:0002013) | 2.33958563 |
| 74 | Reduced antithrombin III activity (HP:0001976) | 2.33059230 |
| 75 | Decreased circulating renin level (HP:0003351) | 2.33028887 |
| 76 | Abnormality of the intrinsic pathway (HP:0010989) | 2.32272758 |
| 77 | Hyperactive renin-angiotensin system (HP:0000841) | 2.31866960 |
| 78 | Hypoalphalipoproteinemia (HP:0003233) | 2.31424717 |
| 79 | Eczematoid dermatitis (HP:0000976) | 2.29200499 |
| 80 | Recurrent abscess formation (HP:0002722) | 2.28954477 |
| 81 | Pustule (HP:0200039) | 2.28286296 |
| 82 | Metabolic alkalosis (HP:0200114) | 2.28259990 |
| 83 | Spontaneous abortion (HP:0005268) | 2.27692480 |
| 84 | Ileus (HP:0002595) | 2.27068904 |
| 85 | Congenital sensorineural hearing impairment (HP:0008527) | 2.25431176 |
| 86 | Prolonged neonatal jaundice (HP:0006579) | 2.25417915 |
| 87 | Abnormality of complement system (HP:0005339) | 2.24022795 |
| 88 | Metaphyseal irregularity (HP:0003025) | 2.23730397 |
| 89 | Late onset (HP:0003584) | 2.22866623 |
| 90 | Amyloidosis (HP:0011034) | 2.21997748 |
| 91 | Recurrent bacterial skin infections (HP:0005406) | 2.21657999 |
| 92 | Increased purine levels (HP:0004368) | 2.21611043 |
| 93 | Hyperuricemia (HP:0002149) | 2.21611043 |
| 94 | Thin bony cortex (HP:0002753) | 2.20182265 |
| 95 | Lipid accumulation in hepatocytes (HP:0006561) | 2.19256317 |
| 96 | Pancreatitis (HP:0001733) | 2.19161428 |
| 97 | Hemorrhage of the eye (HP:0011885) | 2.18258660 |
| 98 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.17793757 |
| 99 | Epidermoid cyst (HP:0200040) | 2.17112679 |
| 100 | Axonal loss (HP:0003447) | 2.14268814 |
| 101 | Abnormality of renin-angiotensin system (HP:0000847) | 2.14176952 |
| 102 | Systemic lupus erythematosus (HP:0002725) | 2.10736159 |
| 103 | Hypercholesterolemia (HP:0003124) | 2.10554347 |
| 104 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.09301034 |
| 105 | Myositis (HP:0100614) | 2.08204389 |
| 106 | Increased cerebral lipofuscin (HP:0011813) | 2.06973934 |
| 107 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.06935392 |
| 108 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.06935392 |
| 109 | Thrombocytosis (HP:0001894) | 2.06860683 |
| 110 | Abdominal distention (HP:0003270) | 2.03496538 |
| 111 | Methylmalonic aciduria (HP:0012120) | 2.03186024 |
| 112 | Spontaneous hematomas (HP:0007420) | 2.03087261 |
| 113 | * Lactic acidosis (HP:0003128) | 2.00774671 |
| 114 | Hepatocellular carcinoma (HP:0001402) | 2.00031224 |
| 115 | Glomerulonephritis (HP:0000099) | 1.99817014 |
| 116 | Hyperphosphaturia (HP:0003109) | 1.99627652 |
| 117 | Mitochondrial inheritance (HP:0001427) | 1.99548343 |
| 118 | Vascular calcification (HP:0004934) | 1.99092293 |
| 119 | Increased CSF lactate (HP:0002490) | 1.96819186 |
| 120 | Abnormal trabecular bone morphology (HP:0100671) | 1.95036341 |
| 121 | Purpura (HP:0000979) | 1.94135664 |
| 122 | Myocardial infarction (HP:0001658) | 1.91145645 |
| 123 | Increased IgM level (HP:0003496) | 1.90894908 |
| 124 | Abnormality of iron homeostasis (HP:0011031) | 1.90893007 |
| 125 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.90885372 |
| 126 | Symptomatic seizures (HP:0011145) | 1.90219551 |
| 127 | * Petechiae (HP:0000967) | 1.89160856 |
| 128 | Abnormality of the costochondral junction (HP:0000919) | 1.88638141 |
| 129 | Renal cortical cysts (HP:0000803) | 1.88544789 |
| 130 | Hepatosplenomegaly (HP:0001433) | 1.88146453 |
| 131 | Irritability (HP:0000737) | 1.88052235 |
| 132 | Neonatal onset (HP:0003623) | 1.87439506 |
| 133 | Progressive neurologic deterioration (HP:0002344) | 1.87244072 |
| 134 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.86829509 |
| 135 | Increased serum ferritin (HP:0003281) | 1.82999941 |
| 136 | Fragile skin (HP:0001030) | 1.82655134 |
| 137 | Joint stiffness (HP:0001387) | 1.82644679 |
| 138 | Renal Fanconi syndrome (HP:0001994) | 1.82538601 |
| 139 | Conjunctival telangiectasia (HP:0000524) | 1.81789307 |
| 140 | Bone pain (HP:0002653) | 1.81225671 |
| 141 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.80893604 |
| 142 | Rough bone trabeculation (HP:0100670) | 1.80401360 |
| 143 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.79817438 |
| 144 | Pili torti (HP:0003777) | 1.79352872 |
| 145 | Nephritis (HP:0000123) | 1.78751405 |
| 146 | Flat acetabular roof (HP:0003180) | 1.78439971 |
| 147 | Elevated hepatic transaminases (HP:0002910) | 1.77870892 |
| 148 | Increased hepatocellular lipid droplets (HP:0006565) | 1.77834035 |
| 149 | Hyperparathyroidism (HP:0000843) | 1.77759900 |
| 150 | Abnormal hair laboratory examination (HP:0003328) | 1.77015839 |
| 151 | Increased serum lactate (HP:0002151) | 1.76741664 |
| 152 | Gingival bleeding (HP:0000225) | 1.75597274 |
| 153 | Gastrointestinal dysmotility (HP:0002579) | 1.75538165 |
| 154 | Alopecia of scalp (HP:0002293) | 1.74204459 |
| 155 | Urticaria (HP:0001025) | 1.72554226 |
| 156 | Hypergammaglobulinemia (HP:0010702) | 1.71847249 |
| 157 | Cervical subluxation (HP:0003308) | 1.70315529 |
| 158 | Right ventricular cardiomyopathy (HP:0011663) | 1.69992113 |
| 159 | Flattened epiphyses (HP:0003071) | 1.69301771 |
| 160 | Hypertensive crisis (HP:0100735) | 1.68648026 |
| 161 | Basal ganglia calcification (HP:0002135) | 1.67409248 |
| 162 | Premature rupture of membranes (HP:0001788) | 1.66373336 |
| 163 | Elevated alkaline phosphatase (HP:0003155) | 1.64334364 |
| 164 | Chronic obstructive pulmonary disease (HP:0006510) | 1.64049524 |
| 165 | Obstructive lung disease (HP:0006536) | 1.64049524 |
| 166 | Autoimmune thrombocytopenia (HP:0001973) | 1.62760021 |
| 167 | Vasculitis (HP:0002633) | 1.61918994 |
| 168 | Hemoptysis (HP:0002105) | 1.61429026 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 4.53370257 |
| 2 | TAOK3 | 4.32021994 |
| 3 | MST1R | 3.89792751 |
| 4 | EPHA2 | 3.13088399 |
| 5 | ERN1 | 3.10432679 |
| 6 | NME2 | 2.81972533 |
| 7 | MYLK | 2.30149546 |
| 8 | PIM2 | 2.25912977 |
| 9 | PIK3CA | 2.15647908 |
| 10 | STK16 | 2.08156628 |
| 11 | KDR | 1.97922166 |
| 12 | FLT3 | 1.91345463 |
| 13 | TESK2 | 1.70943554 |
| 14 | EIF2AK3 | 1.70432429 |
| 15 | MAP2K3 | 1.66251530 |
| 16 | MAP2K2 | 1.66049840 |
| 17 | MAP4K1 | 1.62206394 |
| 18 | MAP3K12 | 1.61717264 |
| 19 | TYK2 | 1.54860122 |
| 20 | ABL2 | 1.50380921 |
| 21 | TBK1 | 1.49435735 |
| 22 | IRAK3 | 1.48912472 |
| 23 | MAP3K11 | 1.45595770 |
| 24 | TAOK2 | 1.45365704 |
| 25 | VRK2 | 1.38501228 |
| 26 | BTK | 1.36224125 |
| 27 | EIF2AK1 | 1.35044257 |
| 28 | BUB1 | 1.34177494 |
| 29 | GRK6 | 1.33629437 |
| 30 | FGFR4 | 1.33561487 |
| 31 | KIT | 1.33521119 |
| 32 | IRAK4 | 1.33006103 |
| 33 | DDR2 | 1.32725150 |
| 34 | MAPK11 | 1.31995078 |
| 35 | PDK2 | 1.31660732 |
| 36 | WEE1 | 1.30919197 |
| 37 | PIK3CG | 1.28065279 |
| 38 | TEC | 1.27348836 |
| 39 | ARAF | 1.25875634 |
| 40 | BLK | 1.24555631 |
| 41 | GRK7 | 1.23273647 |
| 42 | NEK1 | 1.23260516 |
| 43 | LIMK1 | 1.22598148 |
| 44 | STK24 | 1.21344101 |
| 45 | BMPR2 | 0.98319329 |
| 46 | IKBKE | 0.97095519 |
| 47 | CDK19 | 0.96683909 |
| 48 | TESK1 | 0.96581828 |
| 49 | MAPKAPK3 | 0.96495782 |
| 50 | PKN2 | 0.93115176 |
| 51 | NEK9 | 0.93046184 |
| 52 | ERBB4 | 0.92508999 |
| 53 | MAP3K8 | 0.91939304 |
| 54 | MAP3K7 | 0.91700594 |
| 55 | PRKG2 | 0.91665875 |
| 56 | ZAP70 | 0.89823347 |
| 57 | MAP2K6 | 0.88123114 |
| 58 | CSK | 0.85557734 |
| 59 | SMG1 | 0.83818035 |
| 60 | MAP3K14 | 0.83205821 |
| 61 | TXK | 0.82497724 |
| 62 | PIM1 | 0.81466834 |
| 63 | ZAK | 0.81231760 |
| 64 | PRPF4B | 0.80561745 |
| 65 | MAP3K3 | 0.80012108 |
| 66 | LRRK2 | 0.79814582 |
| 67 | MET | 0.79151283 |
| 68 | RPS6KB2 | 0.78607161 |
| 69 | EPHB1 | 0.76953764 |
| 70 | SCYL2 | 0.76890390 |
| 71 | NME1 | 0.76597569 |
| 72 | FRK | 0.74866499 |
| 73 | MAPK4 | 0.74455254 |
| 74 | PTK2 | 0.73576100 |
| 75 | RIPK4 | 0.72756116 |
| 76 | CAMKK2 | 0.72555804 |
| 77 | MATK | 0.71952499 |
| 78 | PAK4 | 0.71810549 |
| 79 | BRSK2 | 0.70504842 |
| 80 | CSF1R | 0.69373291 |
| 81 | MOS | 0.68537267 |
| 82 | BRAF | 0.66594014 |
| 83 | TAOK1 | 0.62170935 |
| 84 | PTK6 | 0.61471428 |
| 85 | SYK | 0.60298930 |
| 86 | JAK2 | 0.60232657 |
| 87 | EEF2K | 0.59136341 |
| 88 | PRKAA2 | 0.57936086 |
| 89 | SIK1 | 0.55805814 |
| 90 | LYN | 0.55508781 |
| 91 | PRKD2 | 0.54646045 |
| 92 | STK10 | 0.54154428 |
| 93 | AURKB | 0.53097672 |
| 94 | DAPK3 | 0.52095041 |
| 95 | EPHB2 | 0.51744379 |
| 96 | PBK | 0.51465968 |
| 97 | CDC42BPA | 0.51453611 |
| 98 | ILK | 0.50801012 |
| 99 | VRK1 | 0.50715277 |
| 100 | ACVR1B | 0.48364976 |
| 101 | INSRR | 0.48223475 |
| 102 | DAPK1 | 0.47906446 |
| 103 | RIPK1 | 0.46875424 |
| 104 | FGR | 0.46008934 |
| 105 | PDPK1 | 0.45341790 |
| 106 | TGFBR1 | 0.45221785 |
| 107 | RPS6KA4 | 0.45075558 |
| 108 | TLK1 | 0.43658696 |
| 109 | MAP3K1 | 0.43423864 |
| 110 | PLK4 | 0.42156602 |
| 111 | LMTK2 | 0.42037279 |
| 112 | IKBKB | 0.41842664 |
| 113 | NLK | 0.41707327 |
| 114 | PINK1 | 0.41512992 |
| 115 | ADRBK2 | 0.41170285 |
| 116 | RPS6KA6 | 0.40755594 |
| 117 | MAPKAPK2 | 0.40700249 |
| 118 | TGFBR2 | 0.40125033 |
| 119 | WNK4 | 0.39972127 |
| 120 | TIE1 | 0.39609119 |
| 121 | JAK3 | 0.39557173 |
| 122 | SIK3 | 0.39307590 |
| 123 | DYRK3 | 0.39110606 |
| 124 | LCK | 0.39011099 |
| 125 | MAP3K5 | 0.38848824 |
| 126 | TTK | 0.37766184 |
| 127 | HCK | 0.37671491 |
| 128 | MAP2K1 | 0.37641696 |
| 129 | PRKCD | 0.37007612 |
| 130 | PRKCI | 0.36606358 |
| 131 | BMX | 0.36510091 |
| 132 | TRPM7 | 0.36184826 |
| 133 | MST4 | 0.35875747 |
| 134 | MAP3K6 | 0.35665713 |
| 135 | PAK1 | 0.34945691 |
| 136 | MAP4K2 | 0.32198701 |
| 137 | ADRBK1 | 0.32119802 |
| 138 | GRK1 | 0.31130029 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.38273668 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.31235337 |
| 3 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.73539135 |
| 4 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.61926835 |
| 5 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.53368460 |
| 6 | Asthma_Homo sapiens_hsa05310 | 2.40943264 |
| 7 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.35764619 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.28152123 |
| 9 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.27407683 |
| 10 | Allograft rejection_Homo sapiens_hsa05330 | 2.20801293 |
| 11 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.13841662 |
| 12 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.13315108 |
| 13 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.06472805 |
| 14 | * Sulfur metabolism_Homo sapiens_hsa00920 | 2.01344001 |
| 15 | Peroxisome_Homo sapiens_hsa04146 | 2.00468354 |
| 16 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.95184925 |
| 17 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.92796954 |
| 18 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.91768702 |
| 19 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.90511505 |
| 20 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.90288523 |
| 21 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.89207329 |
| 22 | Histidine metabolism_Homo sapiens_hsa00340 | 1.82244906 |
| 23 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.79705204 |
| 24 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.79536550 |
| 25 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.78937595 |
| 26 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.76954399 |
| 27 | Sulfur relay system_Homo sapiens_hsa04122 | 1.74318708 |
| 28 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.72958226 |
| 29 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.72587815 |
| 30 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.72153297 |
| 31 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.71099120 |
| 32 | Lysosome_Homo sapiens_hsa04142 | 1.62355790 |
| 33 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.57689646 |
| 34 | Carbon metabolism_Homo sapiens_hsa01200 | 1.57611844 |
| 35 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.53769387 |
| 36 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.51803523 |
| 37 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.51760725 |
| 38 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.49380255 |
| 39 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.47182432 |
| 40 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.45953874 |
| 41 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.41614500 |
| 42 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.41185593 |
| 43 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.40890134 |
| 44 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.40571918 |
| 45 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.39532217 |
| 46 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.38737028 |
| 47 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.37733700 |
| 48 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.37277343 |
| 49 | Retinol metabolism_Homo sapiens_hsa00830 | 1.37190899 |
| 50 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.36296529 |
| 51 | Pertussis_Homo sapiens_hsa05133 | 1.35184683 |
| 52 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.34706545 |
| 53 | Leishmaniasis_Homo sapiens_hsa05140 | 1.31157262 |
| 54 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.29823341 |
| 55 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.25101154 |
| 56 | Bile secretion_Homo sapiens_hsa04976 | 1.24453373 |
| 57 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.23319841 |
| 58 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.19631087 |
| 59 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.17177357 |
| 60 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.12544840 |
| 61 | Ribosome_Homo sapiens_hsa03010 | 1.11767806 |
| 62 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.09869194 |
| 63 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.06770390 |
| 64 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.06744606 |
| 65 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.06198812 |
| 66 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.02154859 |
| 67 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.99233901 |
| 68 | Viral myocarditis_Homo sapiens_hsa05416 | 0.99214307 |
| 69 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.95827064 |
| 70 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.95769100 |
| 71 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.94980370 |
| 72 | Shigellosis_Homo sapiens_hsa05131 | 0.94471768 |
| 73 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.91958098 |
| 74 | Parkinsons disease_Homo sapiens_hsa05012 | 0.91723938 |
| 75 | Salmonella infection_Homo sapiens_hsa05132 | 0.91707978 |
| 76 | Galactose metabolism_Homo sapiens_hsa00052 | 0.91494629 |
| 77 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.91437477 |
| 78 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.90694041 |
| 79 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.90478590 |
| 80 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.88762483 |
| 81 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.87839812 |
| 82 | Tuberculosis_Homo sapiens_hsa05152 | 0.87371015 |
| 83 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.87085472 |
| 84 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.86305223 |
| 85 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.82814016 |
| 86 | Phagosome_Homo sapiens_hsa04145 | 0.80605576 |
| 87 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.80054109 |
| 88 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.79695382 |
| 89 | Proteasome_Homo sapiens_hsa03050 | 0.77879150 |
| 90 | ABC transporters_Homo sapiens_hsa02010 | 0.76576623 |
| 91 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.76375801 |
| 92 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.75593430 |
| 93 | Metabolic pathways_Homo sapiens_hsa01100 | 0.75459944 |
| 94 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.75171842 |
| 95 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.73227887 |
| 96 | Influenza A_Homo sapiens_hsa05164 | 0.71872643 |
| 97 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.71871731 |
| 98 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.70142190 |
| 99 | DNA replication_Homo sapiens_hsa03030 | 0.68437973 |
| 100 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.67908938 |
| 101 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.67466288 |
| 102 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.62928113 |
| 103 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.62241484 |
| 104 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.61682566 |
| 105 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.60151123 |
| 106 | Malaria_Homo sapiens_hsa05144 | 0.57013808 |
| 107 | Other glycan degradation_Homo sapiens_hsa00511 | 0.56575756 |
| 108 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.56506895 |
| 109 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.56383579 |
| 110 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.53554224 |
| 111 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.53524110 |
| 112 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.52925221 |
| 113 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.52201863 |
| 114 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.50085920 |
| 115 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.49997375 |
| 116 | Alzheimers disease_Homo sapiens_hsa05010 | 0.48813980 |
| 117 | Mineral absorption_Homo sapiens_hsa04978 | 0.47930062 |
| 118 | Hepatitis C_Homo sapiens_hsa05160 | 0.44285614 |
| 119 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.44122643 |
| 120 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.43416243 |
| 121 | Huntingtons disease_Homo sapiens_hsa05016 | 0.42795336 |
| 122 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.35684213 |
| 123 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.32511481 |
| 124 | Base excision repair_Homo sapiens_hsa03410 | 0.27750195 |
| 125 | RNA polymerase_Homo sapiens_hsa03020 | 0.23483184 |
| 126 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.20691103 |
| 127 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.18556911 |
| 128 | Lysine degradation_Homo sapiens_hsa00310 | 0.17969577 |
| 129 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.17024594 |
| 130 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.16362594 |
| 131 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.15860148 |
| 132 | Mismatch repair_Homo sapiens_hsa03430 | 0.15154809 |
| 133 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.14957777 |
| 134 | Legionellosis_Homo sapiens_hsa05134 | 0.12961201 |
| 135 | Protein export_Homo sapiens_hsa03060 | 0.12887709 |
| 136 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.11250760 |
| 137 | Purine metabolism_Homo sapiens_hsa00230 | 0.11156544 |
| 138 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.09620863 |

